USFDA nod to Sanofi Sarclisa in combo with bortezomib, lenalidomide, dexamethasone for newly diagnosed multiple myeloma not eligible for transpant Ruchika Sharma21 Sept 2024 2:25 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has approved Sarclisa (isatuximab) in combination with bortezomib,...
Sanofi gets CDSCO marketing nod for RSV treatment Beyfortus in India Ruchika Sharma1 Aug 2024 5:30 PM ISTDrugmaker, Sanofi India, has received marketing authorisation approval from the Central Drugs Standard Control Organisation (CDSCO) for Beyfortus in...
Duchenne muscular dystrophy: Sanofi owned biotech company sues Sarepta Therapeutics over patent infringement Ruchika Sharma31 July 2024 4:02 PM ISTSanofi-owned biotech company Genzyme has initiated a lawsuit against competitor Sarepta Therapeutics in Delaware federal court, accusing the firm of...
Sanofi initiates voluntary recall of Allegra, Combiflam suspensions in India over contamination in some batches Ruchika Sharma23 July 2024 11:30 AM ISTFrench Multinational Pharmaceutical Company Sanofi is voluntarily initiating a precautionary recall of Allegra Suspension syrup...
Dupixent approved in EU as targeted therapy for COPD: Sanofi, Regeneron Pharma Ruchika Sharma3 July 2024 2:00 PM ISTParis: Sanofi and Regeneron Pharmaceuticals has announced that the European Medicines Agency (EMA) has approved Dupixent (dupilumab) as...
Sanofi plans up to USD 1.6 billion investment in Germany: Handelsblatt Ruchika Sharma2 July 2024 2:50 PM ISTFrankfurt: French pharmaceutical company, Sanofi, is close to deciding on an investment ranging between 1.3 billion euros and 1.5 billion euros...
Sanofi names Audrey Duval Derveloy as Executive Vice President, Global Head of Corporate Affairs Ruchika Sharma22 Jun 2024 12:47 PM ISTParis: Sanofi has announced the appointment of Audrey Duval Derveloy, a seasoned healthcare industry leader and Sanofi France's President as...
Sanofi concludes acquisition of Inhibrx Ruchika Sharma2 Jun 2024 11:00 AM ISTParis: Sanofi has announced the completion of its acquisition of Inhibrx, Inc. The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi’s...
USFDA requests additional data on Sanofi Dupixent for treating smoker's lung Ruchika Sharma31 May 2024 3:16 PM ISTParis: Sanofi and Regeneron have announced that the US Food and Drug Administration (FDA) requested additional efficacy analyses on the efficacy...
Sanofi Sarclisa accepted for USFDA priority review for transplant-ineligible newly diagnosed multiple myeloma Ruchika Sharma27 May 2024 11:30 AM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...
Sanofi, Formation Bio, OpenAI collaborate to build AI-powered software to accelerate drug development Ruchika Sharma21 May 2024 9:30 AM ISTParis: Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to...
Sanofi, Novavax ink pact to co-commercialize COVID vaccine, develop novel flu-COVID combination vaccines Ruchika Sharma12 May 2024 10:00 AM ISTParis: Sanofi has entered into a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US to develop...
